Altimmune (ALT) Other Non Operating Income (2010 - 2026)
Altimmune (ALT) reported Other Non Operating Income of -$152000.0 for Q1 2026, down 1113.33% year-over-year from $15000.0 in Q1 2025, and down 462.96% quarter-over-quarter from -$27000.0 in Q4 2025.
Altimmune (ALT) Other Non Operating Income (2010 - 2026) Analysis & Trends
Altimmune (ALT) has 17 years of Other Non Operating Income data on file, last reported at -$152000.0 in Q1 2026.
- Other Non Operating Income for Q1 2026 came in at -$152000.0, down 1113.33% year-over-year; the trailing twelve-month figure through Mar 2026 was -$357000.0 (down 576.0% YoY), and the FY2025 annual result was -$190000.0, down 495.83% from the prior year.
- Other Non Operating Income fell to -$152000.0 in Q1 2026 per ALT's latest filing, from -$27000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $118000.0 in Q4 2024 and troughed at -$217000.0 in Q4 2022.
- A 5-year average of -$9411.8 and a median of $15000.0 in 2025 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2024 and 2026: Other Non Operating Income surged 490.0% in 2024, then slumped 1113.33% in 2026.
- A 5-year view of Other Non Operating Income shows it stood at -$217000.0 in 2022, then surged by 109.22% to $20000.0 in 2023, then surged by 490.0% to $118000.0 in 2024, then slumped by 122.88% to -$27000.0 in 2025, then plunged by 462.96% to -$152000.0 in 2026.
- Business Quant data shows ALT's Other Non Operating Income at -$152000.0 in Q1 2026, -$27000.0 in Q4 2025, and -$86000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Altimmune | 336.67 Mn | 336.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -152,000.00 |
| Dec 31, 2025 | -27,000.00 |
| Sep 30, 2025 | -86,000.00 |
| Jun 30, 2025 | -92,000.00 |
| Mar 31, 2025 | 15,000.00 |
| Dec 31, 2024 | 118,000.00 |
| Sep 30, 2024 | 18,000.00 |
| Jun 30, 2024 | -76,000.00 |
| Mar 31, 2024 | -12,000.00 |
| Dec 31, 2023 | 20,000.00 |
| Sep 30, 2023 | 14,000.00 |
| Jun 30, 2023 | 113,000.00 |
| Mar 31, 2023 | 19,000.00 |
| Dec 31, 2022 | -217,000.00 |
| Sep 30, 2022 | 50,000.00 |
| Jun 30, 2022 | 25,000.00 |
| Mar 31, 2022 | 110,000.00 |
| Dec 31, 2021 | -81,000.00 |
| Sep 30, 2021 | -286,000.00 |
| Jun 30, 2021 | 26,000.00 |